| Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study DH Moore, JA Blessing, RP McQuellon, HT Thaler, D Cella, J Benda, ... Journal of Clinical Oncology 22 (15), 3113-3119, 2004 | 768 | 2004 |
| Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study HJ Long III, BN Bundy, EC Grendys Jr, JA Benda, DS McMeekin, ... Journal of Clinical Oncology 23 (21), 4626-4633, 2005 | 697 | 2005 |
| Lenvatinib plus pembrolizumab for advanced endometrial cancer V Makker, N Colombo, A Casado Herráez, AD Santin, E Colomba, ... New England Journal of Medicine 386 (5), 437-448, 2022 | 521 | 2022 |
| Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 19 (2), 191-226, 2021 | 514 | 2021 |
| Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial KN Moore, AA Secord, MA Geller, DS Miller, N Cloven, GF Fleming, ... The Lancet Oncology 20 (5), 636-648, 2019 | 469 | 2019 |
| Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer D Matei, V Filiaci, ME Randall, D Mutch, MM Steinhoff, PA DiSilvestro, ... New England Journal of Medicine 380 (24), 2317-2326, 2019 | 388 | 2019 |
| Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer YW Huang, JC Liu, DE Deatherage, J Luo, DG Mutch, PJ Goodfellow, ... Cancer research 69 (23), 9038-9046, 2009 | 347 | 2009 |
| Somatic LKB1 mutations promote cervical cancer progression SN Wingo, TD Gallardo, EA Akbay, MC Liang, CM Contreras, T Boren, ... PloS one 4 (4), e5137, 2009 | 333 | 2009 |
| Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study D Miller, V Filiaci, G Fleming, R Mannel, D Cohn, T Matsumoto, K Tewari, ... Gynecologic oncology 125 (3), 771, 2012 | 315* | 2012 |
| Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/carboplatin in high-intermediate and high-risk early-stage endometrial cancer ME Randall, V Filiaci, DS McMeekin, V Von Gruenigen, H Huang, ... Journal of Clinical Oncology 37 (21), 1810-1818, 2019 | 300 | 2019 |
| Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium JR Lurain, BL Rice, AW Rademaker, LE Poggensee, JC Schink, DS Miller Obstetrics & Gynecology 78 (1), 63-69, 1991 | 280 | 1991 |
| Mutations in the BRCAI-Associated RING Domain (BARD1) Gene in Primary Breast, Ovarian and Uterine Cancers TH Thai, F Du, JT Tsan, Y Jin, A Phung, MA Spillman, HF Massa, ... Human molecular genetics 7 (2), 195-202, 1998 | 251 | 1998 |
| Tumor size in endometrial cancer JC Schink, AW Rademaker, DS Miller, JR Lurain Cancer 67 (11), 2791-2794, 1991 | 249 | 1991 |
| Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study JD O'Boyle, RL Coleman, SG Bernstein, S Lifshitz, CY Muller, DS Miller Gynecologic oncology 79 (2), 238-243, 2000 | 242 | 2000 |
| Carboplatin and paclitaxel for advanced endometrial cancer: final overall survival and adverse event analysis of a phase III trial (NRG Oncology/GOG0209) DS Miller, VL Filiaci, RS Mannel, DE Cohn, T Matsumoto, KS Tewari, ... Journal of Clinical Oncology 38 (33), 3841-3850, 2020 | 222 | 2020 |
| The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline A Klopp, BD Smith, K Alektiar, A Cabrera, AL Damato, B Erickson, ... Practical radiation oncology 4 (3), 137-144, 2014 | 206 | 2014 |
| Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group DS Miller, JA Blessing, CN Krasner, RS Mannel, P Hanjani, ML Pearl, ... Journal of Clinical Oncology 27 (16), 2686-2691, 2009 | 194 | 2009 |
| Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study RJ Osborne, V Filiaci, JC Schink, RS Mannel, A Alvarez Secord, JL Kelley, ... Journal of Clinical Oncology 29 (7), 825-831, 2011 | 183 | 2011 |
| Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer JO Schorge, RD Drake, H Lee, SJ Skates, R Rajanbabu, DS Miller, ... Clinical cancer research 10 (10), 3474-3478, 2004 | 173 | 2004 |
| NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022: Featured Updates to the NCCN Guidelines DK Armstrong, RD Alvarez, FJ Backes, JN Bakkum-Gamez, L Barroilhet, ... Journal of the National Comprehensive Cancer Network 20 (9), 972-980, 2022 | 163 | 2022 |
Jayanthi Lea. M.D.; F.A.C.O.G.; F.A.C.S.Professor, Director - Gynecologic Oncology Fellowship Program; UT Southwestern Medical在 utsouthwestern.edu 的电子邮件经过验证
